Avian Chlamydiosis (Psittacosis): Diagnostic Challenges and Public Health Surveillance

Introduction

Avian chlamydiosis, also known as psittacosis or ornithosis, is a bacterial disease caused by Chlamydia psittaci, an obligate intracellular pathogen belonging to the family Chlamydiaceae. The disease affects a wide range of avian species, particularly psittacine birds (parrots, cockatiels, budgerigars), but also pigeons, doves, poultry, and wild waterfowl [1, 2]. C. psittaci is a zoonotic agent capable of causing severe respiratory illness in humans, making its detection and surveillance a critical component of both veterinary and public health systems [3, 4]. This article provides an exhaustive review of the diagnostic challenges associated with avian chlamydiosis, the biological mechanisms underlying host-pathogen interactions, and the surveillance strategies employed in pet and wild bird populations.

Etiology and Pathogenesis

Chlamydia psittaci is a Gram-negative, obligate intracellular bacterium with a biphasic developmental cycle consisting of infectious elementary bodies (EBs) and metabolically active reticulate bodies (RBs) [5]. EBs are environmentally stable and facilitate transmission via inhalation of aerosolized dried feces, respiratory secretions, or feather dust [6]. Once inside a susceptible host, EBs attach to epithelial cells of the respiratory tract and conjunctiva, are internalized via endocytosis, and differentiate into RBs within a membrane-bound inclusion [7]. RBs replicate by binary fission, then re-differentiate into EBs, which are released upon cell lysis to infect neighboring cells [8].

The host immune response is characterized by a strong Th1-mediated inflammatory reaction, with interferon-gamma (IFN-gamma) playing a central role in controlling intracellular replication [9]. However, C. psittaci can evade immune clearance through mechanisms such as inhibition of apoptosis, modulation of cytokine signaling, and persistence in a non-replicating but viable state [10]. Persistent infections are common in carrier birds, which may shed the organism intermittently without clinical signs [11].

Clinical Manifestations in Birds

Clinical signs of avian chlamydiosis vary widely depending on the host species, age, immune status, and C. psittaci genotype [12]. In psittacine birds, acute disease presents with lethargy, anorexia, ruffled feathers, ocular and nasal discharge, conjunctivitis, dyspnea, and biliverdinuria (green urates) [13]. Chronic infections may manifest as weight loss, diarrhea, and intermittent shedding [14]. In pigeons and doves, respiratory signs are less prominent, but splenomegaly and hepatomegaly are common necropsy findings [15]. Poultry, particularly turkeys and ducks, can develop severe respiratory disease with high mortality, while wild waterfowl often remain asymptomatic carriers [16, 17].

Diagnostic Challenges

Diagnosis of avian chlamydiosis is complicated by the intracellular nature of the pathogen, the intermittent shedding pattern, and the lack of pathognomonic clinical signs [18]. No single test offers 100% sensitivity and specificity; therefore, a combination of diagnostic modalities is recommended [19].

Sample Collection and Handling

Appropriate sample selection is critical. Conjunctival swabs, choanal swabs, cloacal swabs, and fresh feces are commonly used for direct detection methods [20]. For serology, plasma or serum is required. Samples should be collected from live birds with minimal stress, as stress can induce shedding in latent carriers [21]. Swabs should be placed in transport medium suitable for chlamydiae (e.g., sucrose-phosphate-glutamate buffer) and kept at 4 degrees Celsius for short-term storage or frozen at -80 degrees Celsius for long-term storage [22].

Molecular Detection: PCR and Real-Time PCR

Polymerase chain reaction (PCR) has become the gold standard for direct detection of C. psittaci due to its high sensitivity and specificity [23]. Conventional PCR targets the ompA gene, which encodes the major outer membrane protein (MOMP), or the 16S rRNA gene [24]. Real-time PCR (qPCR) offers quantitative data and reduced risk of cross-contamination through the use of fluorescent probes [25]. Multiplex PCR panels can differentiate C. psittaci from other chlamydial species such as Chlamydia abortus and Chlamydia pecorum [26].

Despite its advantages, PCR has limitations. False negatives can occur due to low bacterial load, sampling error, or the presence of PCR inhibitors in fecal samples [27]. False positives may arise from laboratory contamination or cross-reactivity with closely related chlamydiae [28]. The use of internal amplification controls and rigorous laboratory protocols is essential to ensure result validity [29].

Serological Methods

Serological tests detect antibodies against C. psittaci and are useful for population screening and identification of past exposure [30]. The complement fixation test (CFT) was historically the standard but has been largely replaced by enzyme-linked immunosorbent assays (ELISAs) and immunofluorescence assays (IFAs) [31]. Commercial ELISA kits for avian chlamydiosis detect anti-MOMP antibodies and offer higher throughput and standardization compared to CFT [32]. However, serology cannot distinguish between active infection and past exposure, and antibody levels may be low in chronically infected or immunosuppressed birds [33].

The Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus provides a comparative example of antigen detection principles, though the target and host differ. In avian chlamydiosis, ELISA-based antibody detection remains a valuable screening tool but must be interpreted in conjunction with PCR results [34].

Culture and Isolation

Cell culture isolation of C. psittaci is technically demanding and requires biosafety level 3 (BSL-3) facilities due to the zoonotic risk [35]. The organism can be propagated in McCoy cells, Vero cells, or embryonated chicken eggs [36]. Culture is rarely used for routine diagnosis but remains important for genotyping and antimicrobial susceptibility testing [37].

Antigen Detection

Direct immunofluorescence (DIF) using monoclonal antibodies against chlamydial lipopolysaccharide (LPS) or MOMP can detect EBs in clinical smears [38]. This method is rapid but requires a fluorescence microscope and experienced personnel. Sensitivity is lower than PCR, particularly in samples with low bacterial load [39].

Comparative Diagnostic Performance

The following table summarizes the diagnostic characteristics of the main detection methods for C. psittaci in avian samples.

Zoonotic Transmission Risks

C. psittaci is a recognized zoonotic pathogen, primarily transmitted to humans via inhalation of aerosolized avian excreta, respiratory secretions, or feather dust [40]. Occupationally exposed individuals, including pet bird owners, avian veterinarians, zoo keepers, and poultry workers, are at highest risk [41]. Human psittacosis typically presents as an influenza-like illness with fever, headache, myalgia, and dry cough, but can progress to severe pneumonia, endocarditis, or encephalitis if untreated [42].

The zoonotic risk underscores the importance of surveillance in both pet and wild bird populations. Outbreaks in humans have been linked to infected psittacine birds in pet shops, aviaries, and households [43]. Wild birds, particularly pigeons and waterfowl, serve as reservoirs and can introduce the pathogen into domestic flocks [44].

Public Health Surveillance Strategies

Surveillance for avian chlamydiosis requires a One Health approach integrating veterinary, environmental, and human health monitoring [45]. Key components include:

• Active surveillance in high-risk populations: Regular testing of psittacine birds in breeding facilities, pet shops, and quarantine stations using PCR and serology [46].
• Passive surveillance of clinical cases: Reporting and diagnostic workup of birds presenting with respiratory or systemic signs consistent with chlamydiosis [47].
• Wild bird monitoring: Sampling of wild pigeons, waterfowl, and migratory birds at stopover sites to detect circulating genotypes and assess spillover risk [48].
• Human case investigation: Epidemiological linkage of human psittacosis cases to avian sources through interview and environmental sampling [49].
• Molecular typing: Genotyping of C. psittaci isolates using ompA sequencing or multilocus sequence typing (MLST) to track transmission chains and identify virulent strains [50].

The following Mermaid diagram illustrates a decision tree for diagnostic workflow and surveillance response.

flowchart TD
    A[Clinical suspicion in bird], > B[Collect swabs: conjunctival, choanal, cloacal]
    B, > C[Perform real-time PCR for C. psittaci]
    C, > D{Result}
    D, >|Positive| E[Confirm with ompA sequencing if needed]
    D, >|Negative| F[Collect serum for ELISA antibody test]
    F, > G{Antibody positive?}
    G, >|Yes| H[Consider recent or past exposure; repeat PCR after 2 weeks]
    G, >|No| I[Low likelihood of active infection; rule out other causes]
    E, > J[Report to veterinary authority]
    J, > K[Initiate treatment: doxycycline]
    K, > L[Isolate bird; implement biosecurity]
    L, > M[Notify public health if human exposure occurred]
    M, > N[Epidemiological investigation of human contacts]
    N, > O[Environmental sampling of aviary or household]
    O, > P[Surveillance data integration for One Health]

Cross-Linking to Related Topics

The diagnostic principles discussed here parallel those used for other avian bacterial pathogens. For example, Avian Pathogenic Escherichia coli (APEC): Virulence Factors, Rapid Diagnostic Assays, and Biosecurity Strategies also relies on PCR and serotyping for detection. Similarly, Salmonella enterica Serovar Typhimurium in Backyard Poultry Flocks: Zoonotic Risk, Antimicrobial Resistance, and Biosecurity highlights the importance of surveillance for zoonotic enteric pathogens. The challenges of intracellular bacterial detection are also relevant to Mycoplasma bovis in Feedlot Cattle: Chronic Pneumonia, Arthritis, and the Challenge of Cultivation versus Molecular Detection. For wild bird reservoirs, Avian Cholera in Waterfowl: Pasteurella multocida Serotypes, Outbreak Dynamics, and Vaccination Approaches in Wild and Domestic Birds provides a comparative perspective on bacterial surveillance in wild populations.

Conclusion

Avian chlamydiosis remains a diagnostic challenge due to the obligate intracellular lifestyle of C. psittaci, intermittent shedding, and the need for specialized laboratory techniques. Real-time PCR offers the highest sensitivity and specificity for direct detection, while serology provides complementary information on exposure history. Zoonotic transmission risks necessitate robust surveillance programs that integrate veterinary and public health systems. Continued development of molecular typing methods and point-of-care diagnostics will enhance the ability to detect and control this pathogen in both pet and wild bird populations.

References

[1] Andersen AA. Serotyping of Chlamydia psittaci isolates using serovar-specific monoclonal antibodies with the microimmunofluorescence test. J Clin Microbiol. 1991;29(4):707-711.

[2] Kaleta EF, Taday EM. Avian host range of Chlamydophila psittaci strains from various sources. Zentralbl Veterinarmed B. 2003;50(3):117-123.

[3] Beeckman DS, Vanrompay DC. Zoonotic Chlamydophila psittaci infections from a clinical perspective. Clin Microbiol Infect. 2009;15(1):11-17.

[4] Harkinezhad T, Geens T, Vanrompay D. Chlamydophila psittaci infections in birds: a review with emphasis on zoonotic consequences. Vet Microbiol. 2009;135(1-2):68-77.

[5] Moulder JW. Interaction of chlamydiae and host cells in vitro. Microbiol Rev. 1991;55(1):143-190.

[6] Vanrompay D, Ducatelle R, Haesebrouck F. Chlamydia psittaci infections: a review with emphasis on avian chlamydiosis. Vet Microbiol. 1995;45(2-3):93-119.

[7] Hackstadt T. Cell biology of Chlamydia. In: Stephens RS, editor. Chlamydia: Intracellular Biology, Pathogenesis, and Immunity. Washington, DC: ASM Press; 1999. p. 101-138.

[8] Abdelrahman YM, Belland RJ. The chlamydial developmental cycle. FEMS Microbiol Rev. 2005;29(5):949-959.

[9] Rottenberg ME, Gigliotti-Rothfuchs A, Wigzell H. The role of IFN-gamma in the outcome of chlamydial infection. Curr Opin Immunol. 2002;14(4):444-451.

[10] Hogan RJ, Mathews SA, Mukhopadhyay S, et al. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun. 2004;72(4):1843-1855.

[11] Wills JM, Watson GE, Gibbs PS, et al. The detection of Chlamydia psittaci in naturally infected birds using a nested PCR. Vet Rec. 1992;131(19):431-434.

[12] Geens T, Desplanques A, Van Loock M, et al. Sequencing of the Chlamydophila psittaci ompA gene reveals a new genotype, E/B, and the need for a rapid discriminatory genotyping method. J Clin Microbiol. 2005;43(5):2456-2461.

[13] Gerlach H. Chlamydia. In: Ritchie BW, Harrison GJ, Harrison LR, editors. Avian Medicine: Principles and Application. Lake Worth, FL: Wingers Publishing; 1994. p. 984-996.

[14] Dorrestein GM, Witter JF. Chlamydiosis in birds. In: Fowler ME, editor. Zoo and Wild Animal Medicine. 3rd ed. Philadelphia: WB Saunders; 1993. p. 227-234.

[15] Salisch H, von Rautenfeld DB, Hinz KH. Pathological and immunohistochemical studies on the occurrence of Chlamydia psittaci in pigeons. Avian Pathol. 1996;25(3):567-580.

[16] Taday EM, Kaleta EF. Chlamydophila psittaci infections in turkeys: a review. Dtsch Tierarztl Wochenschr. 2003;110(6):247-252.

[17] Howerth EW, Stallknecht DE, Davidson WR, et al. Survey for Chlamydia psittaci in free-ranging waterfowl in Georgia. J Wildl Dis. 1991;27(4):682-685.

[18] Sachse K, Vretou E, Livingstone M, et al. Recent developments in the laboratory diagnosis of chlamydial infections. Vet Microbiol. 2009;135(1-2):2-21.

[19] Vanrompay D, Harkinezhad T, van de Walle M, et al. Chlamydophila psittaci transmission from pet birds to humans. Emerg Infect Dis. 2007;13(7):1108-1110.

[20] Hewinson RG, Griffiths PC, Bevan BJ, et al. Detection of Chlamydia psittaci DNA in avian clinical samples by polymerase chain reaction. Vet Microbiol. 1997;54(2):155-166.

[21] Lierz M, Hafez HM, Honkavuori KS, et al. Detection of Chlamydophila psittaci in naturally infected birds by real-time PCR. Avian Dis. 2004;48(4):822-828.

[22] Everett KD, Bush RM, Andersen AA. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, and revised taxonomy of the family Chlamydiaceae. Int J Syst Bacteriol. 1999;49(Pt 2):415-440.

[23] Sachse K, Hotzel H, Slickers P, et al. DNA microarray-based detection and identification of Chlamydia and Chlamydophila spp. Mol Cell Probes. 2005;19(1):41-50.

[24] Kaltenboeck B, Kousoulas KG, Storz J. Two-step polymerase chain reactions and restriction endonuclease analyses detect and differentiate ompA DNA of Chlamydia spp. J Clin Microbiol. 1992;30(5):1098-1104.

[25] Pantchev A, Sting R, Bauerfeind R, et al. New real-time PCR tests for species-specific detection of Chlamydophila psittaci and Chlamydophila abortus from tissue samples. Vet J. 2009;181(2):145-150.

[26] Laroucau K, Vorimore F, Sachse K, et al. Differential identification of Chlamydophila abortus and Chlamydophila psittaci using a species-specific real-time PCR. Vet Microbiol. 2007;124(3-4):354-360.

[27] Wilson IG. Inhibition and facilitation of nucleic acid amplification. Appl Environ Microbiol. 1997;63(10):3741-3751.

[28] Corsaro D, Greub G. Pathogenic potential of novel Chlamydiae and diagnostic approaches to infections due to these obligate intracellular bacteria. Clin Microbiol Rev. 2006;19(2):283-297.

[29] Hoorfar J, Malorny B, Abdulmawjood A, et al. Practical considerations in design of internal amplification controls for diagnostic PCR assays. J Clin Microbiol. 2004;42(5):1863-1868.

[30] Grimes JE, Arizmendi F. Serological diagnosis of chlamydiosis in psittacine birds. J Am Vet Med Assoc. 1992;200(11):1725-1729.

[31] Wills JM, Millard BJ, Gibbs PS, et al. An enzyme-linked immunosorbent assay for the detection of IgG antibodies to Chlamydia psittaci in avian sera. Vet Rec. 1991;128(6):131-134.

[32] Vanrompay D, Cox E, Mast J, et al. Comparison of three serological tests for the detection of Chlamydia psittaci antibodies in psittacine birds. Avian Pathol. 1998;27(4):379-384.

[33] Andersen AA. Comparison of avian Chlamydia psittaci isolates by restriction endonuclease analysis and serovar-specific monoclonal antibodies. J Clin Microbiol. 1991;29(2):244-249.

[34] Lierz M, Hafez HM, Honkavuori KS, et al. Detection of Chlamydophila psittaci in naturally infected birds by real-time PCR. Avian Dis. 2004;48(4):822-828.

[35] Storz J. Chlamydia and Chlamydia-Induced Diseases. Springfield, IL: Charles C Thomas; 1971.

[36] Schachter J, Dawson CR. Human Chlamydial Infections. Littleton, MA: PSG Publishing; 1978.

[37] Suchland RJ, Geisler WM, Stamm WE. Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp. Antimicrob Agents Chemother. 2003;47(2):636-642.

[38] Stephens RS, Tam MR, Kuo CC, et al. Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization. J Immunol. 1982;128(3):1083-1089.

[39] Thejls H, Gnarpe J, Gnarpe H, et al. Expanded gold standard in the diagnosis of Chlamydia trachomatis in a low prevalence population: diagnostic efficacy of tissue culture, direct immunofluorescence, enzyme immunoassay, PCR and serology. Genitourin Med. 1994;70(5):300-303.

[40] Harkinezhad T, Verminnen K, De Buyzere M, et al. Prevalence of Chlamydophila psittaci infections in a human population in contact with domestic and companion birds. J Med Microbiol. 2009;58(Pt 9):1207-1212.

[41] Smith KA, Bradley KK, Stobierski MG, et al. Compendium of measures to control Chlamydophila psittaci (formerly Chlamydia psittaci) infection among humans (psittacosis) and pet birds. J Am Vet Med Assoc. 2005;226(4):532-539.

[42] Yung AP, Grayson ML. Psittacosis: a review of 135 cases. Med J Aust. 1988;148(5):228-233.

[43] Moroney JF, Guevara R, Iverson C, et al. Detection of chlamydiosis in a shipment of pet birds, leading to recognition of an outbreak of clinically mild psittacosis in humans. Clin Infect Dis. 1998;26(6):1425-1429.

[44] Franson JC, Pearson JE. Chlamydiosis in wild birds. In: Thomas NJ, Hunter DB, Atkinson CT, editors. Infectious Diseases of Wild Birds. Ames, IA: Blackwell Publishing; 2007. p. 241-258.

[45] Borel N, Polkinghorne A, Pospischil A. A review on chlamydial diseases in animals: still a challenge for pathologists? Vet Pathol. 2018;55(3):374-390.

[46] Laroucau K, Aaziz R, Vorimore F, et al. A cluster of psittacosis cases in France linked to a pet bird shop. Zoonoses Public Health. 2015;62(6):463-468.

[47] Dickx V, Vanrompay D. Zoonotic transmission of Chlamydia psittaci from birds to humans: a systematic review. Vet Microbiol. 2011;147(3-4):209-221.

[48] Kaleta EF, Taday EM. Chlamydophila psittaci infections in free-living birds: a review. Berl Munch Tierarztl Wochenschr. 2003;116(9-10):373-380.

[49] Williams J, Tallis G, Dalton C, et al. Community outbreak of psittacosis in a rural Australian town. Lancet. 1998;351(9117):1697-1699.

[50] Pannekoek Y, Dickx V, Beeckman DS, et al. Multi locus sequence typing of Chlamydia reveals an association between Chlamydia psittaci genotypes and host species. PLoS One. 2010;5(12):e14179.